Switch to previous version of Magzter

BioSpectrum Asia - November 2018Add to Favorites

Get BioSpectrum Asia along with 5,000+ other magazines & newspapers

Try FREE for 7 days

bookLatest and past issues of 5,000+ magazines & newspapersphoneDigital Access. Cancel Anytime.familyShare with 4 family members.

1 Year$99.99

bookLatest and past issues of 5,000+ magazines & newspapersphoneDigital Access. Cancel Anytime.familyShare with 4 family members.
(Or)

Get BioSpectrum Asia

1 Year $11.99

book12 issues starting from March 2020 phoneDigital Access. Cancel Anytime.

Buy this issue $0.99

bookNovember 2018 issue phoneDigital Access.

Gift BioSpectrum Asia

  • Magazine Details
  • In this issue

Magazine Description

In this issue

South Korea – leading biosimilars opportunities for Asia Historically, Asia has led in generics adoption and now, with more than 300 biosimilars under development, Asia is one of the leading regions for global biosimilars development. The foundations have been laid for the biosimilar industry in Korea, providing an opportunity for the region to become a global center for manufacturing and adoption of biosimilars in the next few decades. Just as Indian companies have carved out a leading position in the generic drug market, South Korean companies are poised to take leading positions in the biosimilars industry in the coming years.

  • cancel anytimeCancel Anytime [ No Commitments ]
  • digital onlyDigital Only